Compare TLSI & NAKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLSI | NAKA |
|---|---|---|
| Founded | 2010 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 265.2M |
| IPO Year | N/A | 2024 |
| Metric | TLSI | NAKA |
|---|---|---|
| Price | $5.91 | $0.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $11.50 | $4.50 |
| AVG Volume (30 Days) | 212.5K | ★ 12.6M |
| Earning Date | 11-13-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,207,000.00 | $1,980,278.00 |
| Revenue This Year | $55.06 | N/A |
| Revenue Next Year | $46.04 | $2,774.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.52 | N/A |
| 52 Week Low | $3.42 | $0.34 |
| 52 Week High | $7.95 | $34.77 |
| Indicator | TLSI | NAKA |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 51.48 |
| Support Level | $5.60 | $0.35 |
| Resistance Level | $7.20 | $0.52 |
| Average True Range (ATR) | 0.48 | 0.04 |
| MACD | -0.23 | 0.03 |
| Stochastic Oscillator | 12.98 | 84.85 |
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.